References

Adagra C, Foster DJ Hyperammonaemia in four cats with renal azotaemia. J Feline Med Surg. 2015; 17:(2)168-172 https://doi.org/10.1177/1098612X14527083

Auron A, Brophy PD Hyperammonemia in review: pathophysiology, diagnosis, and treatment. Pediatr Nephrol. 2012; 27:(2)207-222 https://doi.org/10.1007/s00467-011-1838-5

Bailiff NL, Westropp JL, Jang SS, Ling GV Corynebacterium urealyticum urinary tract infection in dogs and cats: 7 cases (1996–2003). J Am Vet Med Assoc. 2005; 226:(10)1676-1680 https://doi.org/10.2460/javma.2005.226.1676

Briscoe KA, Barrs VR, Lindsay S Encrusting cystitis in a cat secondary to Corynebacterium urealyticum infection. J Feline Med Surg. 2010; 12:(12)972-977 https://doi.org/10.1016/j.jfms.2010.07.007

Butterworth RF Ammonia removal by metabolic scavengers for the prevention and treatment of hepatic encephalopathy in cirrhosis. Drugs R D. 2021; 21:(2)123-132 https://doi.org/10.1007/s40268-021-00345-4

Carvalho L, Kelley D, Labato MA, Webster CR Hyperammonemia in azotemic cats. J Feline Med Surg. 2021; 23:(8)700-707 https://doi.org/10.1177/1098612X20972039

Cavana P, Zanatta R, Nebbia P Corynebacterium urealyticum urinary tract infection in a cat with urethral obstruction. J Feline Med Surg. 2008; 10:(3)269-273 https://doi.org/10.1016/j.jfms.2007.12.003

Culler CA, Reinhardt A, Vigani A Successful management of clinical signs associated with hepatic encephalopathy with manual therapeutic plasma exchange in a dog. J Vet Emerg Crit Care (San Antonio). 2020; 30:(3)312-317 https://doi.org/10.1111/vec.12940

Dor C, Adamany JL, Kisielewicz C, de Brot S, Erles K, Dhumeaux MP Acquired urea cycle amino acid deficiency and hyperammonaemic encephalopathy in a cat with inflammatory bowel disease and chronic kidney disease. JFMS Open Rep. 2018; 4:(2) https://doi.org/10.1177/2055116918786750

Goggs R, Serrano S, Szladovits B, Keir I, Ong R, Hughes D Clinical investigation of a point-of-care blood ammonia analyzer. Vet Clin Pathol. 2008; 37:(2)198-206 https://doi.org/10.1111/j.1939-165X.2008.00024.x

Häberle J Primary hyperammonaemia: current diagnostic and therapeutic strategies. J Mother Child. 2020; 24:(2)32-38 https://doi.org/10.34763/jmotherandchild.20202402si.2015.000006

Hall JA, Allen TA, Fettman MJ Hyperammonemia associated with urethral obstruction in a dog. J Am Vet Med Assoc. 1987; 191:(9)1116-1118

Havig M, Tobias KM Outcome of ameroid constrictor occlusion of single congenital extrahepatic portosystemic shunts in cats: 12 cases (1993–2000). J Am Vet Med Assoc. 2002; 220:(3)337-341 https://doi.org/10.2460/javma.2002.220.337

Hung TY, Chen CC, Wang TL, Su CF, Wang RF Transient hyperammonemia in seizures: a prospective study. Epilepsia. 2011; 52:(11)2043-2049 https://doi.org/10.1111/j.1528-1167.2011.03279.x

Karim N, Dawod G, Henkel ND, Sheikh AA Risk factors associated with hyperammonemia following unprovoked convulsive seizures. Cureus. 2020; 12:(6) https://doi.org/10.7759/cureus.8504

Levitt MD, Levitt DG Use of quantitative modelling to elucidate the roles of the liver, gut, kidney, and muscle in ammonia homeostasis and how lactulose and rifaximin alter this homeostasis. Int J Gen Med. 2019; 12:367-380 https://doi.org/10.2147/IJGM.S218405

Liu KT, Yang SC, Yeh IJ, Lin TJ, Lee CW Transient hyperammonemia associated with postictal state in generalized convulsion. Kaohsiung J Med Sci. 2011; 27:(10)453-456 https://doi.org/10.1016/j.kjms.2011.06.005

Lopes FF, Sitta A, de Moura Coelho D Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy. Int J Dev Neurosci. 2022; 82:(8)772-788 https://doi.org/10.1002/jdn.10229

Maurey C, Boulouis HJ, Canonne-Guibert M, Benchekroun G Clinical description of Corynebacterium urealyticum urinary tract infections in 11 dogs and 10 cats. J Small Anim Pract. 2019; 60:(4)239-246 https://doi.org/10.1111/jsap.12973

Mohammad RA, Regal RE, Alaniz C Combination therapy for the treatment and prevention of hepatic encephalopathy. Ann Pharmacother. 2012; 46:(11)1559-1563 https://doi.org/10.1345/aph.1R146

Morris JG Idiosyncratic nutrient requirements of cats appear to be diet-induced evolutionary adaptations. Nutr Res Rev. 2002; 15:(1)153-168 https://doi.org/10.1079/NRR200238

Morris JG, Rogers QR Ammonia intoxication in the near-adult cat as a result of a dietary deficiency of arginine. Science. 1978; 199:(4327)431-432 https://doi.org/10.1126/science.619464

Nakamura K, Yamane K, Shinohara K Hyperammonemia in idiopathic epileptic seizure. Am J Emerg Med. 2013; 31:(10)1486-1489 https://doi.org/10.1016/j.ajem.2013.08.003

Nilsson CH, Svensson MB, Säve SJ, Van Meervenne SA Transient hyperammonaemia following epileptic seizures in cats. J Feline Med Surg. 2021; 23:(6)534-539 https://doi.org/10.1177/1098612X20962747

Pirotte J, Guffens JM, Devos J Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose. Digestion. 1974; 10:(6)435-444 https://doi.org/10.1159/000197556

Ravindranath A, Sarma MS Mitochondrial hepatopathy: anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects. World J Hepatol. 2022; 14:(1)180-194 https://doi.org/10.4254/wjh.v14.i1.180

Ruland K, Fischer A, Hartmann K Sensitivity and specificity of fasting ammonia and serum bile acids in the diagnosis of portosystemic shunts in dogs and cats. Vet Clin Pathol. 2010; 39:(1)57-64 https://doi.org/10.1111/j.1939-165X.2009.00178.x

Sato K, Arai N, Omori A, Hida A, Kimura A, Takeuchi S Hyperammonaemia and associated factors in unprovoked convulsive seizures: A cross-sectional study. Seizure. 2016; 43:6-12 https://doi.org/10.1016/j.seizure.2016.09.015

Serrano G, Devriendt N, de Rooster H, Paepe D Comparison of diet, lactulose, and metronidazole combinations in the control of pre-surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts. J Vet Intern Med. 2022; 36:(4)1258-1266 https://doi.org/10.1111/jvim.16464

Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013; 108:(9)1458-1463 https://doi.org/10.1038/ajg.2013.219

Simpson K, Battersby I, Lowrie M Suspected acquired hypocobalaminaemic encephalopathy in a cat: resolution of encephalopathic signs and MRI lesions subsequent to cobalamin supplementation. J Feline Med Surg. 2012; 14:(5)350-355 https://doi.org/10.1177/1098612X12439358

Sugimoto S, Maeda S, Tsuboi M Multiple acquired portosystemic shunts secondary to primary hypoplasia of the portal vein in a cat. J Vet Med Sci. 2018; 80:(6)874-877 https://doi.org/10.1292/jvms.17-0648

Tivers M, Lipscomb V Congenital portosystemic shunts in cats: investigation, diagnosis and stabilisation. J Feline Med Surg. 2011; 13:(3)173-184 https://doi.org/10.1016/j.jfms.2011.01.010

Vaden SL, Wood PA, Ledley FD, Cornwell PE, Miller RT, Page R Cobalamin deficiency associated with methylmalonic acidemia in a cat. J Am Vet Med Assoc. 1992; 200:(8)1101-1103

Valiente P, Trehy M, White R Complications and outcome of cats with congenital extrahepatic portosystemic shunts treated with thin film: thirty-four cases (2008–2017). J Vet Intern Med. 2020; 34:(1)117-124 https://doi.org/10.1111/jvim.15649

Vaziri ND, Wong J, Pahl M Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013; 83:(2)308-315 https://doi.org/10.1038/ki.2012.345

Walker V Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem. 2014; 67:73-150 https://doi.org/10.1016/bs.acc.2014.09.002

Washizu T, Washizu M, Zhang C, Matsumoto I, Sawamura M, Suzuki T A suspected case of ornithine transcarbamylase deficiency in a cat. J Vet Med Sci. 2004; 66:(6)701-703 https://doi.org/10.1292/jvms.66.701

Watanabe T, Hoshi K, Zhang C, Ishida Y, Sakata I Hyperammonaemia due to cobalamin malabsorption in a cat with exocrine pancreatic insufficiency. J Feline Med Surg. 2012; 14:(12)942-945 https://doi.org/10.1177/1098612X12458101

Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND Expansion of urease- and uricase-containing, indole-and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014; 39:(3)230-237 https://doi.org/10.1159/000360010

Worhunsky P, Toulza O, Rishniw M The relationship of serum cobalamin to methylmalonic acid concentrations and clinical variables in cats. J Vet Intern Med. 2013; 27:(5)1056-1063 https://doi.org/10.1111/jvim.12152

Zandvliet MM, Szatmári V, van den Ingh T, Rothuizen J Acquired portosystemic shunting in 2 cats secondary to congenital hepatic fibrosis. J Vet Intern Med. 2005; 19:(5)765-767 https://doi.org/10.1892/0891-6640(2005)19[765apsics]2.0.co;2

Hyperammonaemia in cats

02 April 2024
15 mins read
Volume 29 · Issue 4

Abstract

Ammonia is an important nitrogen source required for amino acid, protein and nucleic acid synthesis. In addition, it plays an essential role in the kidney's maintenance of acid–base balance. However, high concentrations of ammonia are cytotoxic and clinical signs primarily reflect neurotoxicity. The body detoxifies ammonia through the urea cycle in the liver or by consuming ammonia in the conversion of glutamate to glutamine in the liver, brain and muscle tissue. The most common cause of hyperammonaemia in cats is congenital portosystemic shunting. Additional causes include cobalamin or arginine deficiency, disruption of the urea cycle by congenital enzyme deficiencies or acute liver failure, excessive muscle activity, infections with urease-producing bacteria, kidney disease and multiple acquired portosystemic shunts.

The metabolism of ammonia is complex, yet a vitally important process required to maintain physiological homeostasis. Ammonia production is a by-product of the catabolism of nitrogen sources, most notably ingested protein and amino acids. Since ammonia is neurotoxic at high systemic blood concentrations, efficient mechanisms exist to compartmentalise the production and elimination of ammonia to maintain safe levels. The liver is the major player in ammonia excretion, while the intestine and kidney are the main ammonia producers. The liver can also generate ammonia, and the intestines and kidney can aid in ammonia excretion. Muscle can serve as an ammonia sink and in some cases increase ammonia load, which adds to the complexity of this process.

Ammonia is a biologically important source of nitrogen required for amino acid, protein and nucleic acid synthesis (Walker, 2014; Häberle, 2020; Butterworth, 2021). Additionally, ammonia plays a pivotal role in the kidney's maintenance of acid–base balance. Most ammonia is generated in the gastrointestinal tract from the action of urease-producing microbes on dietary and endogenous proteins (Table 1). The generated ammonia freely diffuses across the intestinal epithelium and makes its way into the portal blood. Additional sources of ammonia production include enterocyte metabolism of glutamine to glutamate in the intestine and kidney which releases ammonia, skeletal muscle production through the purine nucleotide cycle following strenuous exercise and hydrolysis of urea by urease-producing microbes in the gastrointestinal tract (Table 1).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.